Cargando…

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis

PURPOSE: Several randomized controlled clinical trials have been conducted to investigate the role of carvedilol and propranolol on the effect of portal pressure in patients with cirrhosis, leading to controversial results. Current meta-analysis was performed to compare the efficacy of the two drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Sheng, Wang, Jin-Jun, Wang, Qin-Qin, Hu, Jun-Wei, Dong, Shuang, Hu, Li-Juan, Jian, Yi-Cheng, Liu, Xin-Yan, Yang, Gen-Mei, Xiong, Wu-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508063/ https://www.ncbi.nlm.nih.gov/pubmed/26203230 http://dx.doi.org/10.2147/PPA.S84762

Ejemplares similares

Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety
por: Razafindrazoto, Chantelli Iamblaudiot, et al.
Publicado: (2022)

CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN PORTAL HYPERTENSION MODEL IN RATS
por: BERTOLDI, Andressa de Souza, et al.
Publicado: (2020)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
por: Wani, Zeeshan Ahmad, et al.
Publicado: (2017)

Severe carvedilol toxicity without overdose – caution in cirrhosis
por: Maharaj, Satish, et al.
Publicado: (2017)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: A Prospective Cohort Study
por: Sinkala, Edford, et al.
Publicado: (2020)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension
por: Ding, Xiang-Chun, et al.
Publicado: (2018)

A Preclinical Porcine Model of Portal Vein Thrombosis in Liver Cirrhosis
por: Zhang, Rui, et al.
Publicado: (2020)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Elective Splenectomy Combined with Modified Hassab's or Sugiura Procedure for Portal Hypertension in Decompensated Cirrhosis
por: Zhang, Ya-wu, et al.
Publicado: (2019)

Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
por: Yao, Hongjuan, et al.
Publicado: (2020)

Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats
por: Ling, Liping, et al.
Publicado: (2018)

A Nomogram for Predicting Portal Hypertensive Gastropathy in Patients With Liver Cirrhosis: A Retrospective Analysis
por: Wang, WenSheng, et al.
Publicado: (2022)

Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension
por: Guo, Yangkun, et al.
Publicado: (2023)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis
por: Rezayat, Kambiz Akhavan, et al.
Publicado: (2017)

AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
por: Hu, Liangshuo, et al.
Publicado: (2019)

Portal Hypertensive Polyps as Gastroscopic Finding in Liver Cirrhosis
por: Topal, Firdevs, et al.
Publicado: (2020)

Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2022)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2013)

Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension
por: Wei, Zhen-gang, et al.
Publicado: (2018)

Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study
por: GURGHEAN, ADRIANA V., et al.
Publicado: (2017)

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2011)

Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
por: Garcia‐Tsao, Guadalupe, et al.
Publicado: (2018)

Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series
por: Zheng, Dan, et al.
Publicado: (2021)

Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis
por: Serna-Salas, Sandra Alejandra, et al.
Publicado: (2018)

Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
por: Reboredo, Mercedes, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_17f95tpi5jt5or6buacelffmt8